No Data
Revelation Biosciences, Inc. Completes the GMP Manufacture of Gemini Clinical Drug Supply
12 Health Care Stocks Moving In Monday's Pre-Market Session
Why Revelation Biosciences Shares Are Trading Higher By Around 49%; Here Are 20 Stocks Moving Premarket
Revelation Biosciences Shares Are Trading Higher After the Company Reported Better-than-expected Q3 EPS Results.
Revelation Biosciences Sees Funding Sufficient Into 2025 >REVB
Press Release: Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2024
No Data
No Data